Sciencast Management LP Takes $708,000 Position in STERIS plc (NYSE:STE)

Sciencast Management LP bought a new stake in shares of STERIS plc (NYSE:STE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,442 shares of the medical equipment provider's stock, valued at approximately $708,000.

A number of other institutional investors and hedge funds also recently modified their holdings of STE. Avalon Trust Co acquired a new stake in STERIS during the fourth quarter worth about $30,000. Human Investing LLC bought a new position in shares of STERIS during the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC raised its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division raised its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC lifted its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares during the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Performance

Shares of NYSE:STE traded up $1.29 on Thursday, hitting $224.35. The company's stock had a trading volume of 503,563 shares, compared to its average volume of 503,569. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock's 50-day moving average is $221.95 and its two-hundred day moving average is $221.61. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company has a market capitalization of $22.04 billion, a price-to-earnings ratio of 47.63 and a beta of 0.92.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS's payout ratio is currently 48.41%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Stephens restated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. JMP Securities restated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.